Novel Form of Curcumin Improves Endothelial Function in Young, Healthy Individuals: A Double-Blind Placebo Controlled Study

Table 1

Baseline demographics of the experimental cohort partitioned by treatment group.

Parameter	Treatment group	Mean + SD
Age (y)	Placebo	20.8 ± 1.8
	50 mg	21.2 ± 2.3
	200 mg	21.7 ± 2.4
Stature (cm)	Placebo	170.6 ± 8.2
	50 mg	173.7 ± 9.3
	200 mg	169.2 ± 9.9
Weight (kg)	Placebo	69.8 ± 11.3
	50 mg	73.2 ± 14.9
	200 mg	66.9 ± 14.6
Body mass index (kg⋅m^−2)	Placebo	23.9 ± 2.6
	50 mg	24.1 ± 3.4
	200 mg	23.1 ± 3.1
Systolic blood pressure (mmHg)	Placebo	116.9 ± 7.3
	50 mg	115.7 ± 7.5
	200 mg	118.3 ± 6.0
Diastolic blood pressure (mmHg)	Placebo	74.6 ± 6.6
	50 mg	71.4 ± 8.3
	200 mg	77.8 ± 6.6
Resting HR (beats⋅min^−1)	Placebo	73.7 ± 8.4
	50 mg	74.8 ± 7.5
	200 mg	74.9 ± 10.4
Maximal oxygen consumption (mL⋅kg⋅min^−1)	Placebo	41.6 ± 6.0
	50 mg	43.7 ± 7.1
	200 mg	44.1 ± 7.6

Sample size per group: PLA, 21; 50 mg, 19; 200 mg, 19.